AR036037A1 - Compuesto heterociclico, composicion farmaceutica que lo comprende y su uso para la preparacion de esta ultima - Google Patents
Compuesto heterociclico, composicion farmaceutica que lo comprende y su uso para la preparacion de esta ultimaInfo
- Publication number
- AR036037A1 AR036037A1 ARP020102003A ARP020102003A AR036037A1 AR 036037 A1 AR036037 A1 AR 036037A1 AR P020102003 A ARP020102003 A AR P020102003A AR P020102003 A ARP020102003 A AR P020102003A AR 036037 A1 AR036037 A1 AR 036037A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- hydrogen atom
- aryl
- pharmaceutical composition
- agent
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 title 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 4
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 3
- 125000004209 (C1-C8) alkyl group Chemical group 0.000 abstract 3
- 125000003118 aryl group Chemical group 0.000 abstract 3
- 125000003545 alkoxy group Chemical group 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- 238000011321 prophylaxis Methods 0.000 abstract 2
- 238000011282 treatment Methods 0.000 abstract 2
- 206010003210 Arteriosclerosis Diseases 0.000 abstract 1
- 125000004648 C2-C8 alkenyl group Chemical group 0.000 abstract 1
- 206010022489 Insulin Resistance Diseases 0.000 abstract 1
- 102000003728 Peroxisome Proliferator-Activated Receptors Human genes 0.000 abstract 1
- 108090000029 Peroxisome Proliferator-Activated Receptors Proteins 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 230000003579 anti-obesity Effects 0.000 abstract 1
- 239000003524 antilipemic agent Substances 0.000 abstract 1
- 208000011775 arteriosclerosis disease Diseases 0.000 abstract 1
- 125000002102 aryl alkyloxo group Chemical group 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003623 enhancer Substances 0.000 abstract 1
- 150000002391 heterocyclic compounds Chemical class 0.000 abstract 1
- 230000002218 hypoglycaemic effect Effects 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 125000004430 oxygen atom Chemical group O* 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229910052717 sulfur Chemical group 0.000 abstract 1
- 125000004434 sulfur atom Chemical group 0.000 abstract 1
- 208000011580 syndromic disease Diseases 0.000 abstract 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Child & Adolescent Psychology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
Un compuesto heterocíclico que tiene la fórmula (1) donde R1 es un átomo de hidrógeno o alquilo C1-6; R2 es -CO-C(R4)=C(R4)-R5, donde R4 es un átomo de hidrógeno o alquilo C1-4; y R5 es alquilo C4-8, alquenilo C2-8, arilo o heterociclo aromático, -CO-C:::C-R6, donde R6 es alquilo C1-8, CO-CO-R7, donde R7 es alquilo C1-8 o alcoxi C1-8, -N(R8)-CO-R9, donde R8 es un átomo de hidrógeno o alquilo C1-4; y R9 es alquilo C1-8, alcoxi C1-8, arilo o arilalcoxi C1-3, o arilo; R3 es un átomo de hidrógeno o alquilo C1-4; X es un átomo de oxígeno o un átomo de azufre; R20 es fenilo opcionalmente sustituido; y n es un número entero de 1 a 4, o una sal farmacéuticamente aceptable del mismo. Composición farmacéutica que lo comprende y su uso para prepararla, siendo esta última útil como agente hipoglucémico, hipolipidémico, un mejorador de la resistencia a la insulina, agente antiarterioesclerosis, antiobesidad, antinflamatorio, agente para la profilaxis o el tratamiento de enfermedades mediadas por PPAR y para la profilaxis o el tratamiento del síndrome X.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001161488 | 2001-05-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR036037A1 true AR036037A1 (es) | 2004-08-04 |
Family
ID=19004755
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP020102003A AR036037A1 (es) | 2001-05-29 | 2002-05-29 | Compuesto heterociclico, composicion farmaceutica que lo comprende y su uso para la preparacion de esta ultima |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US6872732B2 (es) |
| EP (1) | EP1398313A4 (es) |
| JP (1) | JP4279137B2 (es) |
| KR (1) | KR100874677B1 (es) |
| CN (1) | CN1522253A (es) |
| AR (1) | AR036037A1 (es) |
| AU (1) | AU2002308891B2 (es) |
| BR (1) | BR0209735A (es) |
| CA (1) | CA2448639A1 (es) |
| CO (1) | CO5540322A2 (es) |
| CZ (1) | CZ20033415A3 (es) |
| HU (1) | HUP0400023A2 (es) |
| IL (1) | IL159084A0 (es) |
| MX (1) | MXPA03010867A (es) |
| NO (1) | NO326559B1 (es) |
| NZ (1) | NZ530313A (es) |
| PL (1) | PL367676A1 (es) |
| RU (1) | RU2287529C2 (es) |
| TW (1) | TWI243172B (es) |
| WO (1) | WO2002096904A1 (es) |
| YU (1) | YU94203A (es) |
| ZA (1) | ZA200309513B (es) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA03010811A (es) * | 2001-05-29 | 2004-02-27 | Kyoto Pharma Ind | Compuestos heterociclico y uso farmaceutico. |
| US6833380B2 (en) | 2002-03-07 | 2004-12-21 | Warner-Lambert Company, Llc | Compounds that modulate PPAR activity and methods of preparation |
| US6867224B2 (en) * | 2002-03-07 | 2005-03-15 | Warner-Lambert Company | Compounds that modulate PPAR activity and methods of preparation |
| US7528160B2 (en) | 2003-01-06 | 2009-05-05 | Eli Lilly And Company | Fused heterocyclic derivatives as PPAR modulators |
| US7244763B2 (en) * | 2003-04-17 | 2007-07-17 | Warner Lambert Company Llc | Compounds that modulate PPAR activity and methods of preparation |
| US6987118B2 (en) | 2003-05-21 | 2006-01-17 | Pfizer Inc. | Tetrahydroisoquinoline derivatives as PPAR-alpha activators |
| JP4805552B2 (ja) * | 2003-05-30 | 2011-11-02 | 武田薬品工業株式会社 | 縮合環化合物 |
| EP1630152A4 (en) * | 2003-05-30 | 2009-09-23 | Takeda Pharmaceutical | CONDENSED CYCLIC COMPOUND |
| TWI359810B (en) * | 2004-11-04 | 2012-03-11 | Mitsubishi Tanabe Pharma Corp | Carboxylic acid derivative containing thiazole rin |
| WO2007126043A1 (ja) * | 2006-04-27 | 2007-11-08 | Mitsubishi Tanabe Pharma Corporation | チアゾール環を含むカルボン酸誘導体の医薬用途 |
| WO2012033195A1 (ja) * | 2010-09-10 | 2012-03-15 | 京都薬品工業株式会社 | 複素環化合物 |
| ES2702951T3 (es) | 2014-04-04 | 2019-03-06 | Syros Pharmaceuticals Inc | Inhibidores de quinasas dependientes de ciclina 7 (cdk7) |
| WO2020013116A1 (ja) * | 2018-07-10 | 2020-01-16 | 京都薬品工業株式会社 | Ｐｔｐ－１ｂ阻害剤およびその用途 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6051189A (ja) * | 1983-08-30 | 1985-03-22 | Sankyo Co Ltd | チアゾリジン誘導体およびその製造法 |
| AR240698A1 (es) * | 1985-01-19 | 1990-09-28 | Takeda Chemical Industries Ltd | Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales |
| DE3856378T2 (de) * | 1987-09-04 | 2000-05-11 | Beecham Group P.L.C., Brentford | Substituierte Thiazolidindionderivate |
| US5246943A (en) | 1992-05-19 | 1993-09-21 | Warner-Lambert Company | Substituted 1,2,3,4-tetahydroisoquinolines with angiotensin II receptor antagonist properties |
| GB9604242D0 (en) | 1996-02-28 | 1996-05-01 | Glaxo Wellcome Inc | Chemical compounds |
| WO1998000403A1 (en) | 1996-07-01 | 1998-01-08 | Eli Lilly And Company | Hypoglycemic and hypolipidemic compounds |
| CA2259487A1 (en) | 1996-07-01 | 1998-01-08 | Margaret Mary Faul | Hypoglycemic and hypolipidemic compounds |
| GB9817118D0 (en) * | 1998-08-07 | 1998-10-07 | Glaxo Group Ltd | Pharmaceutical compounds |
| CA2393265A1 (en) * | 1999-12-03 | 2001-06-07 | Kyoto Pharmaceutical Industries, Ltd. | Novel heterocyclic compounds and salts thereof and medicinal use of the same |
| US20020037897A1 (en) | 2000-08-07 | 2002-03-28 | 3-Dimensional Pharmaceuticals, Inc. | Tetrahydroisoquinoline-3-carboxylic acid alkoxyguanidines as integrin antagonists |
| MXPA03010811A (es) | 2001-05-29 | 2004-02-27 | Kyoto Pharma Ind | Compuestos heterociclico y uso farmaceutico. |
-
2002
- 2002-05-27 RU RU2003137576/04A patent/RU2287529C2/ru not_active IP Right Cessation
- 2002-05-27 US US10/478,863 patent/US6872732B2/en not_active Expired - Fee Related
- 2002-05-27 IL IL15908402A patent/IL159084A0/xx unknown
- 2002-05-27 PL PL02367676A patent/PL367676A1/xx not_active IP Right Cessation
- 2002-05-27 EP EP02774071A patent/EP1398313A4/en not_active Withdrawn
- 2002-05-27 MX MXPA03010867A patent/MXPA03010867A/es active IP Right Grant
- 2002-05-27 NZ NZ530313A patent/NZ530313A/en unknown
- 2002-05-27 CZ CZ20033415A patent/CZ20033415A3/cs unknown
- 2002-05-27 YU YU94203A patent/YU94203A/sh unknown
- 2002-05-27 JP JP2003500083A patent/JP4279137B2/ja not_active Expired - Fee Related
- 2002-05-27 CN CNA028109627A patent/CN1522253A/zh active Pending
- 2002-05-27 AU AU2002308891A patent/AU2002308891B2/en not_active Ceased
- 2002-05-27 WO PCT/JP2002/005098 patent/WO2002096904A1/ja not_active Ceased
- 2002-05-27 CA CA002448639A patent/CA2448639A1/en not_active Abandoned
- 2002-05-27 KR KR1020037015518A patent/KR100874677B1/ko not_active Expired - Fee Related
- 2002-05-27 BR BR0209735-4A patent/BR0209735A/pt not_active IP Right Cessation
- 2002-05-27 HU HU0400023A patent/HUP0400023A2/hu unknown
- 2002-05-28 TW TW091111323A patent/TWI243172B/zh not_active IP Right Cessation
- 2002-05-29 AR ARP020102003A patent/AR036037A1/es unknown
-
2003
- 2003-11-28 NO NO20035332A patent/NO326559B1/no unknown
- 2003-12-08 ZA ZA200309513A patent/ZA200309513B/xx unknown
- 2003-12-29 CO CO03112805A patent/CO5540322A2/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200309513B (en) | 2004-12-08 |
| IL159084A0 (en) | 2004-05-12 |
| EP1398313A4 (en) | 2005-11-16 |
| TWI243172B (en) | 2005-11-11 |
| YU94203A (sh) | 2006-08-17 |
| WO2002096904A1 (en) | 2002-12-05 |
| KR20040004663A (ko) | 2004-01-13 |
| EP1398313A1 (en) | 2004-03-17 |
| PL367676A1 (en) | 2005-03-07 |
| NO20035332D0 (no) | 2003-11-28 |
| HUP0400023A2 (hu) | 2004-04-28 |
| CN1522253A (zh) | 2004-08-18 |
| CA2448639A1 (en) | 2002-12-05 |
| AU2002308891B2 (en) | 2007-09-06 |
| BR0209735A (pt) | 2004-07-27 |
| JP4279137B2 (ja) | 2009-06-17 |
| KR100874677B1 (ko) | 2008-12-18 |
| NZ530313A (en) | 2005-06-24 |
| RU2287529C2 (ru) | 2006-11-20 |
| MXPA03010867A (es) | 2004-02-27 |
| US20040180924A1 (en) | 2004-09-16 |
| CO5540322A2 (es) | 2005-07-29 |
| NO326559B1 (no) | 2009-01-12 |
| CZ20033415A3 (cs) | 2004-06-16 |
| RU2003137576A (ru) | 2005-05-20 |
| US6872732B2 (en) | 2005-03-29 |
| JPWO2002096904A1 (ja) | 2004-09-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR036037A1 (es) | Compuesto heterociclico, composicion farmaceutica que lo comprende y su uso para la preparacion de esta ultima | |
| UA74391C2 (uk) | Арил- або гетероарилконденсовані імідазоли як антизапальні і анальгетичні агенти | |
| AR020661A1 (es) | Una composicion farmaceutica topica oftalmica, otica o nasal y el uso de la misma para la manufactura de un medicamento | |
| EA200971041A1 (ru) | Новые пептидные ингибиторы репликации вируса гепатита с | |
| EA200971026A1 (ru) | Новые макроциклические ингибиторы репликации вируса гепатита с | |
| ATE530066T1 (de) | Verbindungen zur behandlung von stoffwechselstörungen | |
| NO20003399D0 (no) | <Alfa>-amionoamidderivater som er nyttige som smertestillende midler | |
| PE20081493A1 (es) | Nuevos derivados de 1,4-benzotiepina-1,1-dioxido sustituidos con radicales bencilo, metodo para su preparacion, productos farmaceuticos que comprenden estos compuestos y su uso | |
| CY1111310T1 (el) | Ενωσεις για την αγωγη μεταβολικων διαταραχων | |
| WO2004073611A3 (en) | Compounds for the treatment of metabolic disorders | |
| ATE526018T1 (de) | Verbindungen zur behandlung von stoffwechselstörungen | |
| ATE450496T1 (de) | Verbindungen zur behandlung von stoffwechselstörungen | |
| ATE337318T1 (de) | Spiroverbindungen und diese als wirkstoff enthaltende adhäsionsmolekülinhibitoren | |
| AR036036A1 (es) | Compuesto heterociclico, composicion farmaceutica que lo contiene y su uso para la preparacion de la misma | |
| BRPI0811245A2 (pt) | Composto de carbamoilóxi-aril-alcanoil-aril-piperazinas, composições farmacêuticas que compreendem o composto, e método para tratar dor, ansiedade e depressão administrando o composto. | |
| BRPI0617918B8 (pt) | compostos de fórmula (i) e seu uso, medicamentos e composição farmacêutica | |
| EA201070603A1 (ru) | Лекарственное средство, активное в отношении невропатической боли | |
| AR044869A1 (es) | Compuesto de dicetopiperazina, composicion farmaceutica que lo comprende, su uso para fabricar un medicamento y procedimiento para su preparacion | |
| AR054707A1 (es) | Derivados de octahidropirrolo 3,4-c pirrol, un procedimiento para su preparacion, una composicion farmaceutica y uso del compuesto para la fabricacion de un medicamento | |
| DE602004019778D1 (de) | Verwendung von 2-amino-1,3-propandiolderivaten zur herstellung eines medikaments zur behandlung von bestimmten schmerzen | |
| ES2059348T3 (es) | Composicion farmaceutica para el tratamiento de cataratas. | |
| BR9917315A (pt) | Composições medicinais para liberação imediata para uso oral | |
| ATE540675T1 (de) | Verbindungen zur behandlung von stoffwechselstörungen | |
| IL150100A0 (en) | Pharmaceutical compositions containing fused cyclic compounds | |
| AR058915A1 (es) | Compuestos aromaticos nitrogenados, composiciones farmaceuticas que los contienen y su uso en la fabricacion de un medicamento para el tratamiento de una enfermedad mediada por la modulacion de mch1. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |